Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

innoscripta Aktie 145239394 / DE000A40QVM8

21.08.2025 07:55:45

EQS-News: innoscripta reports successful first half of 2025

EQS-News: innoscripta SE / Key word(s): Half Year Results/Half Year Report
innoscripta reports successful first half of 2025

21.08.2025 / 07:55 CET/CEST
The issuer is solely responsible for the content of this announcement.


Munich, August 21, 2025 – innoscripta SE (the “Company”; ISIN: DE000A40QVM8), a leading provider of cloud-based soft-ware solutions for tax incentives for research and development (R&D) in Germany, has published its financial report for the first half of 2025.

innoscripta SE looks back on a successful first half of the year. The Company further increased its revenue, net income and number of customers:

•    Number of customers: 2,100 customers (H1/2024: 1,400 customers)
•    Consolidated revenue: €44.10 million (H1/2024: €22.89 million) ? +93%
•    Consolidated EBIT: €23.80 million (H1/2024: €10.47 million) ? +127%
•    Consolidated EBIT margin: 54% (H1/2024: 45%)
•    Consolidated net income after taxes: €15.99 million (H1/2024: €7.15 million) ? +124%

This growth was achieved in particular through the optimization of digital processes, the continuous development of our Clus-terix platform, and the targeted expansion of scalability and efficiency. The number of customers grew by 17% to around 2,100 in the first six months, which corresponds to an increase of approximately 300 customers (December 31, 2024: 1,800 customers). At the same time, the average number of employees rose to 337 (H1/2024: 247).

Michael Hohenester, Founder and CEO of innoscripta, explains:
“innoscripta remains on a clear and sustainable growth path, driven by strong demand from both our existing and new custom-ers. This confirms the strength and relevance of our software solution for German companies.”

Alexander Meyer, Co-CEO and CFO, adds:
“In the first half of the year, we succeeded in significantly increasing consolidated revenue while further improving EBIT – thanks to our consistent focus on efficiency and cost discipline. We have thus achieved the best result in our Company's history and consistently continued our successful growth course in fiscal year 2025.”

The Company currently believes that all conditions are in place for the business to continue on its long-term growth path. 

innoscripta SE will present its results for the first half of 2025 in a presentation today, Thursday, August 21, 2025, at 3 p.m. CEST.
If you are interested in participating, please contact Investor Relations (ir@innoscripta.com) to receive the access details.

The complete consolidated half-yearly financial report as of June 30, 2025, is available for download in the “Investors” section of the Company's website.

About innoscripta
innoscripta SE is a leading provider of cloud-based software solutions for tax incentives for research and development (R&D) in Germany. With its Clusterix platform, the company supports over 2,100 companies in applying for, documenting, and managing tax research allowances. innoscripta has been listed in the Scale segment of the Frankfurt Stock Exchange since May 2025 (ticker: 1INN).

 


21.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: innoscripta SE
Arnulfstrasse 60
80335 München
Germany
Phone: +4989262004187
E-mail: info@innoscripta.com
Internet: https://www.innoscripta.com
ISIN: DE000A40QVM8
WKN: A40QVM
Listed: Regulated Unofficial Market in Dusseldorf, Frankfurt (Scale), Munich, Tradegate Exchange
EQS News ID: 2186722

 
End of News EQS News Service

2186722  21.08.2025 CET/CEST

Analysen zu innoscripta SE Inhaber-Akt

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Erfolgsfaktoren hinter starker Performance – Karsten-Dirk Steffens zu Gast im BX Morningcall

Einmal pro Monat laden Investment-Stratege François Bloch und Börsen-Experte David Kunz spannende Persönlichkeiten aus der Finanzbranche zum Interview ein.

In einem exklusiven Gespräch gibt Karsten-Dirk Steffens, CEO Schweiz von Aberdeen Investments, Einblicke in seine persönliche Motivation, die Entwicklung des Unternehmens in der Schweiz sowie die wichtigsten Trends für institutionelle und private Anleger.

Themen des Interviews:

– 15 Jahre Aberdeen Investments in der Schweiz – Rückblick und Zukunft
– Unterschiede zwischen institutionellen Kunden und internationalen Investoren
– Aktuelle Schwerpunkte bei Pensionskassen und Versicherungen (u. a. Aktienallokation)
– Nachhaltigkeit & ESG – Renaissance für Privatanleger vs. klare Standards bei Pensionskassen
– Alternative Anlagen: Private Markets, Infrastruktur, Private Debt
– Demokratisierung von Private Markets
– Chancen durch Digitalisierung, Blockchain und Tokenisierung

👉🏽 https://bxplus.ch/bx-musterportfolio/

Erfolgsfaktoren hinter starker Performance – Karsten-Dirk Steffens zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’680.37 19.68 ISSMNU
Short 12’957.14 13.56 B1LSOU
Short 13’438.91 8.81 B6CSKU
SMI-Kurs: 12’195.98 15.09.2025 13:20:40
Long 11’638.76 18.35 S7MBDU
Long 11’412.17 13.71 BK5S8U
Long 10’915.15 8.84 BPOSGU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}